Hexadecanamide, N-[(1S,2R,3E,7E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-, (2R)-
Hexadecanamide, N-[1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxy-, [1S-[1R*(S*),2S*,3E,7E]]-
Hexadecanamide, N-[(1S,2R,3E,7E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxy-, (2R)-
(2R)-N-[(1S,2R,3E,7E)-1-[(β-D-Glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxyhexadecanamide
Soyacerebroside I
(2S,3R,4E,8E)-1-O-β-D-Glucopyranosyl-3-hydroxy-2-(2′R-hydroxypalmitoylamino)-4,8-octadecadiene
(2R)-N-[(1S,2R,3E,7E)-1-[(β-D-Glucopyranosyloxy)methyl]-2-hydroxyheptadeca-3,7-dien-1-yl]-2-hydroxyhexadecanamide
1-O-β-D-Glucopyranosyl-(2S,3R,4E,8E)-2-[(2′R)-2-hydroxyhexadecanoylamino]-4,8-octadecadiene-1,3-diol